Bharat Immunologicals Corporate Bonds and Current Financial Leverage

BIBCL -- India Stock  

INR 16.15  0.95  5.56%

Bharat Immunologicals financial leverage is the degree to which the firm utilises its fixed-income securities. Companies with high leverage are usually considered to be at financial risk. Bharat Immunologicals financial risk is the risk to Bharat Immunologicals stockholders that is caused by an increase in debt. In other words with a high degree of financial leverage come high interest payments which usually reduces Earnings Per Share (EPS). Check also Trending Equities.

Bharat Immunologicals Financial Leverage Rating

Not Rated
Total Macroaxis Rating
 
N/A
Average S&P Rating

Bharat Immunologicals Debt to Cash Allocation

The company has accumulated 14.53 M in total debt with debt to equity ratio (D/E) of 3.8 implying the company greatly relies on financing operations through barroing. Bharat Immunologicals Biologicals Corp Ltd has Current Ratio of 1.66 which is within standard range for the sector.

Did you try this?

Run Commodity Channel Index Now
   

Commodity Channel Index

Use Commodity Channel Index to analyze current equity momentum
All  Next Launch Commodity Channel Index

Pair Correlation

Equities Pair Trading Analysis
Correlation analysis and pair trading evaluation for Bharat Immunologicals and Tata Consultancy Ser. Pair trading can be used as a hedging technique within a particular sector or industry or even over random equities to generate better risk-adjusted return
Run Pair Correlation  
Check also Trending Equities. Please also try Portfolio Reporting module to create custom reports across your portfolios and generate quick suggestion pitch.